Filter
1789
Filtered Results: 1789
Text search:
tb
costs
Featured
Recommendations
163
New Publications
538
Language
Document type
No document type
1165
Studies & Reports
257
Guidelines
185
Manuals
63
Strategic & Response Plan
63
Fact sheets
21
Training Material
15
Situation Updates
9
Infographics
7
Resource Platforms
3
Brochures
1
Countries / Regions
India
85
Kenya
81
Global
62
South Africa
61
Western and Central Europe
50
Zambia
42
Ethiopia
40
Africa
39
Uganda
38
Malawi
34
Nepal
31
Tanzania
31
Eastern Europe
30
Nigeria
29
Liberia
29
Myanmar / Burma
29
Sierra Leone
27
Rwanda
26
Latin America and the Carribbean
26
Ghana
24
Bangladesh
22
Namibia
22
Cambodia
20
Ukraine
19
South–East Asia Region
19
Asia
18
Lesotho
17
Zimbabwe
15
Philippines
14
Botswana
13
East and Southern Africa
12
Mozambique
11
Indonesia
9
Syria
8
Senegal
8
Congo, Democratic Republic of
7
South Sudan
7
Pakistan
7
Haiti
6
West and Central Africa
6
Russia
6
Georgia
6
Colombia
5
Benin
5
Guinea
5
Germany
5
Middle East and North Africa
5
Vietnam
5
Albania
4
Western Pacific Region
4
Timor Leste/ East Timor
3
Thailand
3
Cameroon
3
Laos
3
Burkina Faso
3
Armenia
3
Jordan
3
North America
3
Southern Africa
3
Sudan
3
Tajikistan
2
Iran
2
Peru
2
Venezuela
2
Eastern Europe and Central Asia
2
Argentina
2
Lebanon
2
Papua New Guinea
2
Brazil
2
Moldova
2
Sri Lanka
2
Central African Republic
2
Poland
2
Iraq
2
Eswatini/ Swaziland
2
North Macedonia
1
North Korea
1
Serbia
1
China
1
Singapore
1
Estonia
1
Afghanistan
1
Burundi
1
Morocco
1
Bulgaria
1
USA
1
Hungary
1
Ireland
1
Saudi Arabia
1
Turkmenistan
1
Jamaica
1
Maldives
1
Tunisia
1
Israel
1
Côte d’Ivoire / Ivory Coast
1
Yemen
1
Romania
1
Greece
1
Angola
1
Chad
1
Bhutan
1
Somalia
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
740
Clinical Guidelines
135
Public Health
87
Key Resources
45
Women & Child Health
43
Pharmacy & Technologies
23
Capacity Building
17
Annual Report MEDBOX
2
Toolboxes
TB
331
HIV
247
AMR
80
COVID-19
55
Mental Health
43
NTDs
36
Pharmacy
35
Caregiver
34
Global Health Education
32
Health Financing Toolbox
28
NCDs
26
Disability
25
Refugee
24
Planetary Health
22
Conflict
19
Polio
16
Rapid Response
13
Natural Hazards
13
Ebola
13
Social Ethics
5
Specific Hazards
2
Zika
2
South Sudan
1
Cholera
1
Health Financing
1
Global Tuberculosis Report 2022 Factsheet
recommended
The World Health Organization Global TB Report provides a comprehensive and up-to-date assessment of the TB epidemic, and progress in the response, at global, regional and country levels.
The 2022 edition features data on disease trends and the response to the epidemic from 215 countries and area...
Stop TB Communicable Diseases
The purpose of the PAS III is to guide Pakistan’s overall national response for HIV and AIDS through 2020, through focused interventions with set targets, costs, roles and responsibilities. The successful implementation of PAS III involves multiple stakeholders to achieve priority outcomes outline...
The review’s objectives are to review progress in TB control with emphasis on DOTS strategy implementation, summarize the experience, lessons learnt and methods of work and to make recommendations for international donors, technical agencies and the Ministry of Health.
WHO consolidated guidelines on tuberculosis: module 1: prevention: tuberculosis preventive treatment
The 2020 recommendations for the programmatic management of TB preventive treatment are the first to be released under the rubric of WHO consolidated TB guidelines (Module 1 – Prevention). The WHO consolidated TB guidelines will gradually group all TB recommendations and will be complemented by ma...
This document summarizes the results of the WHO-commissioned full value proposition for new tuberculosis (TB) vaccines. The assessment was commissioned to provide early evidence for national and global decision-makers involved in TB vaccine development and implementation, who include stakeholders in...
Guidance on TB and TB/HIV prevention, diagnosis, treatment and care in the workplace
2nd edition.
T The Compendium has been developed as a clear and concise instrument to facilitate the understanding and planning of delivery of high-quality care for everybody affected by TB. It incorporates all recent policy guidance from WHO; follows the care pathway of persons with signs or sympt...
The aim of the people-centred framework is to help countries to develop fully prioritized and budgeted NSPs based on a culture of making full use of the available data, which are aligned with national planning cycles and which provide the basis for a robust national response that can accelerate prog...
Screening programmes for tuberculosis (TB) among immigrants rarely consider the heterogeneity of
risk related to migrants’ country of origin. We assess the performance of a large screening programme in asylum seekers by analysing (i) the difference in yield and numbers needed to screen (NNS) by c...
Global tuberculosis report 2022
recommended
The WHO Global Tuberculosis Report 2022 provides a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease, at global, regional and country levels. This is done in the context of global TB commitments, strategies and targets.
...
Information note.
This information note provides a strategic overview of key implementation considerations for diagnostic integration using these devices, and is primarily intended for use by national laboratory services and TB, HIV, and hepatitis programme managers.
It may also be of inte...
This information note provides a strategic overview of key implementation considerations for diagnostic integration using these devices, and is primarily intended for use by national laboratory services and TB, HIV, and hepatitis programme managers.
It may also be of inte...
A review of available evidence (2016).
28-29 June 2016; Geneva, Switzerland
The END TB strategy.
Framework for implementation.
The END TB Strategy.
KNCV Tuberculosis Foundation - Your Partner in the fight against TB
Accessed November 2017
Regional Eastern European and Central Asian project (TB-REP) Copenhagen, Denmark, 26–28 April 2016
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
Latent Tuberculosis Infection : Updated and consolidated guidelines for programmatic management
recommended
The consolidated guidelines are expected to provide the basis and rationale for the development of national guidelines for LTBI management, adapted to the national and local epidemiology of TB, the availability of resources, the health infrastructure and other national and local determinants. The gu...
